Implementation of a protocol for ABO-incompatible kidney transplantation - A three-center experience with 60 consecutive transplantations

Transplantation

Volumn 83, Issue 9, 2007, Pages 1153-1155

  Tydén, Gunnar ^a   Donauer, Johannes ^b   Wadström, Jonas ^c   Kumlien, Gunilla ^a   Wilpert, Jochen ^b   Nilsson, Thomas ^c   Genberg, Helena ^a   Pisarski, Przemislaw ^b   Tufveson, Gunnar ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ABO incompatible; Antigen specific; Immunoadsorption; Rituximab

Indexed keywords

BLOOD GROUP ANTIBODY; COTRIMOXAZOLE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RITUXIMAB; TACROLIMUS; VALACICLOVIR; VALGANCICLOVIR;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; APHERESIS; APPARATUS; ARTICLE; BLOOD COMPATIBILITY; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FOLLOW UP; GERMANY; GRAFT FAILURE; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURVIVAL; SWEDEN; VIRUS INFECTION;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; BLOOD GROUP INCOMPATIBILITY; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; INFANT; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

EID: 34248396788     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000262570.18117.55     Document Type: Article

References (10)

1. Tydén G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76: 730.
2. Tydén G, Kumlien G, Genberg H, et al. The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy. Xenotransplantation 2006; 13: 105.
3. Donauer J, Wilpert J, Geyer M, et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A single center experience. Xenotransplantation 2006; 13: 108.
4. Kumlien G, Ullström L, Losvall A, Persson LG, Tydén G. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006; 46: 1568.
5. Ishida H, Tanabe K, Ishizuka T, et al. Differences in humoral immunity between a non-rejection group and a rejection group after ABO-incompatible renal transplantation. Transplantation 2006; 81: 665.
6. Gloor JM, Lager DJ, Moore SB, et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75: 971.
7. Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004; 4: 1315.
8. Tanabe K, Tokumoto T, Ishida H, et al. Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroids. Transplant Proc 2004; 36: 2175.
9. Mannami M, Mitsuhata N. Improved outcomes after ABO-incompatible living-donor kidney transplantation after 4 weeks of treatment with mycophenolate mofetil. Transplantation 2005; 79: 1756.
10. Kobayashi T, Saito K. A series of surveys on assay for anti-A/B antibody by Japanese ABO-incompatible Transplantation Committee. Xenotransplantation 2006; 13: 136.